Skip to content
Temple University logo

Technology Commercialization Office

Visit program ↗Check the fit ↓
About the program · 1 linked sources

The Technology Commercialization Office, under the Office of the Vice President for Research, provides comprehensive support from invention disclosure and patenting to licensing and startup formation. Manages IP protection and commercialization strategies for Temple innovations. Contact: Stephen Nappi, Associate Vice President of Technology Commercialization and Business Development.

Also known as: Temple Technology Commercialization, OTCBD

How we know this: the figures on this page come from the linked sources (last verified 2026-06-24); what those sources do not state is left unknown.

Key numbers

Funding range

Not listed

Equity

Varies by investment

Application

Ongoing

Campus Wide

Last activity

2026-06-24

High confidence

Keep this on your radar Deadline reminders ↓

Reminders

Technology Commercialization Office

Get an email before a director-verified deadline for this program, this school, or this state. The program never sees your address.

Student experiences · Read or add a note

Student notes

Technology Commercialization Office

No posts yet.

    Post what happened. A .edu account is required. Your name and email stay off this page.

    Rating

    0/280

    Application and Timing

    Ongoing, year-round. No fixed deadline; triggered by invention disclosures.

    Participants

    Temple faculty, researchers, students, and external partners licensing Temple IP.

    Funding and Equity

    Facilitates licensing deals and startup formation. May enable access to grants and investment but not a direct grant program. Equity/royalty terms negotiated per deal.

    Recent Activity

    • Active through 2023-2026 with integration into iNest and broader innovation initiatives.
    • Temple ranked top 100 nationally for patents awarded (2024).
    • Continuous pipeline of invention disclosures and licensing.

    Known Startups or Winners

    Numerous Temple spinouts, including those incubated at iNest (Thrombolex, SFA Therapeutics, Inovele, Oral Biolife). Ladder Bio (2026, Blue Bell, PA) developing oral treatments for injected medications.

    Research gaps & things to verify

    Verification Gaps

    • Annual metrics: patents filed, licenses executed, startups formed.
    • Standard licensing terms and equity/royalty structures.
    Additional research notesShow

    Evidence

    • Official Technology Commercialization page.[1]
    • Research report.[2]